 |
|
The Efficacy of Bisphosphonates for Prevention of Osteoporotic Fracture: An Update Meta-analysis
Ji-Hye Byun, Sunmee Jang, Sumin Lee, Suyeon Park, Hyun Koo Yoon, Byung-Ho Yoon, Yong-Chan Ha
J Bone Metab. 2017;24(1):37-49. Published online 2017 Feb 28 DOI: https://doi.org/10.11005/jbm.2017.24.1.37
|
|
Citations to this article as recorded by
 Anti-osteoporosis drugs reduce mortality in cancer patients: A national cohort study of elderly with vertebral fractures
Chun-Feng Huan, Tzu-Tung Kuo, Jason C Hsu, Russell O Kosik, Wing P Chan
Annals of the Academy of Medicine, Singapore.2024; 53(1): 6. CrossRef Sacroplasty for Sacral Insufficiency Fractures: Narrative Literature Review on Patient Selection, Technical Approaches, and Outcomes
Manjot Singh, Mariah Balmaceno-Criss, Ashley Knebel, Michael Kuharski, Itala Sakr, Mohammad Daher, Christopher L. McDonald, Bassel G. Diebo, John K. Czerwein, Alan H. Daniels
Journal of Clinical Medicine.2024; 13(4): 1101. CrossRef Conditional loss of CaMKK2 in Osterix-positive osteoprogenitors enhances osteoblast function in a sex-divergent manner
Brett T. Mattingly, Anuradha Valiya Kambrath, Xinchun Ding, William R. Thompson, Uma Sankar
Bone.2024; : 117113. CrossRef Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians
Chelsea Ayers, Devan Kansagara, Brittany Lazur, Rongwei Fu, Amy Kwon, Curtis Harrod
Annals of Internal Medicine.2023; 176(2): 182. CrossRef The association between multimorbidity and osteoporosis investigation and treatment in high-risk fracture patients in Australia: A prospective cohort study
Dana Bliuc, Thach Tran, Weiwen Chen, Dunia Alarkawi, Dima A. Alajlouni, Fiona Blyth, Lyn March, Kristine E. Ensrud, Robert D. Blank, Jacqueline R. Center, Christelle Nguyen
PLOS Medicine.2023; 20(1): e1004142. CrossRef An overview of the management of osteoporosis in the aging female population
Usman Amin, Aoife McPartland, Miriam O’Sullivan, Carmel Silke
Women's Health.2023; 19: 174550572311766. CrossRef Cost-effectiveness of opportunistic QCT-based osteoporosis screening for the prediction of incident vertebral fractures
Sebastian Rühling, Julian Schwarting, Matthias F. Froelich, Maximilian T. Löffler, Jannis Bodden, Moritz R. Hernandez Petzsche, Thomas Baum, Maria Wostrack, A. Kaywan Aftahy, Vanadin Seifert-Klauss, Nico Sollmann, Claus Zimmer, Jan S. Kirschke, Fabian Tol
Frontiers in Endocrinology.2023;[Epub] CrossRef Exploring the impact of an instructional web-based healthcare app for relieving back pain from spinal compression fractures: an observational study
Pei-Hung Liao, William Chu
Multimedia Tools and Applications.2023; 83(11): 33295. CrossRef Clinicians’ views of prescribing oral and intravenous bisphosphonates for osteoporosis: a qualitative study
Simon Bishop, Melanie Jay Narayanasamy, Zoe Paskins, Nadia Corp, Anastasios Bastounis, Jill Griffin, Neil Gittoes, Jo Leonardi-Bee, Tessa Langley, Opinder Sahota
BMC Musculoskeletal Disorders.2023;[Epub] CrossRef The Potential Therapeutic Effects of Platelet-Derived Biomaterials on Osteoporosis: A Comprehensive Review of Current Evidence
Mohammad Amin Amiri, Nima Farshidfar, Richard J. Miron, Arkadiusz Dziedzic, Shahram Hamedani, Sajad Daneshi, Lobat Tayebi, Weihao Yuan
International Journal of Biomaterials.2023; 2023: 1. CrossRef Comparison of different predicting models to assist the diagnosis of spinal lesions
William Chu, Chen-Shie Ho, Pei-Hung Liao
Informatics for Health and Social Care.2022; 47(1): 92. CrossRef Identifying temporal patterns of adherence to antidepressants, bisphosphonates and statins, and associated patient factors
Kyu Hyung Park, Leonie Tickle, Henry Cutler
SSM - Population Health.2022; 17: 100973. CrossRef Importance of Time Point–Specific Indirect Treatment Comparisons of Osteoporosis Treatments: A Systematic Literature Review and Network Meta-Analyses
Damon Willems, Muhammad Kassim Javaid, Rafael Pinedo-Villanueva, Cesar Libanati, Alon Yehoshua, Mata Charokopou
Clinical Therapeutics.2022; 44(1): 81. CrossRef Application of Machine Learning in Developing Decision-Making Support Models for Decompressed Vertebroplasty
Pei-Hung Liao, Yu-Chuan Tsuei, William Chu
Healthcare.2022; 10(2): 214. CrossRef Race and Age Impact Osteoporosis Screening Rates in Women Prior to Hip Fracture
Gregory Benes, Justin David, Molly Synowicz, Alex Betech, Vinod Dasa, Peter C. Krause, Deryk Jones, Lauren Hall, Lauren Leslie, Andrew G. Chapple
Archives of Osteoporosis.2022;[Epub] CrossRef Comparative efficacy and safety of bisphosphonate therapy for bone loss in individuals after middle age: A systematic review and network meta-analysis
Qin Hu, Xun Pan, Yaxian Liang, Hongdan Xu, Jinning Gu, Wenting She, Huixu Xie
Nano TransMed.2022; 1(1): 9130003. CrossRef El caso de la osteoporosis
Alberto López García-Franco, Ana Pereira Iglesias, Anabel González Prats, Elena Cardona Corrochano
FMC - Formación Médica Continuada en Atención Primaria.2022; 29(4): 209. CrossRef Analysis of the effects of curcumin and symbiotic consumption on bones of rats submitted to the use of dexamethasone
Julia Aparecida Galdino Torralba de Oliveira, Mariana Daudt Neves, Gleicy Fernanda Soares Sampaio, Carlos José Leopoldo Constantino, Wilson Romero Nakagaki
Life Sciences.2022; 304: 120690. CrossRef Acceptability and engagement amongst patients on oral and intravenous bisphosphonates for the treatment of osteoporosis in older adults
Melanie Narayanasamy, Simon Bishop, Opinder Sahota, Zoe Paskins, Neil Gittoes, Tessa Langley
Age and Ageing.2022;[Epub] CrossRef A Mini Review on Osteoporosis: From Biology to Pharmacological Management of Bone Loss
Kok-Yong Chin, Ben Nett Ng, Muhd Khairik Imran Rostam, Nur Farah Dhaniyah Muhammad Fadzil, Vaishnavi Raman, Farzana Mohamed Yunus, Syed Alhafiz Syed Hashim, Sophia Ogechi Ekeuku
Journal of Clinical Medicine.2022; 11(21): 6434. CrossRef The Contribution of Multimorbidity to Under-Diagnosis and Under-Treatment of Osteoporosis in High-Risk Fracture Patients
Dana Bliuc, Thach T. Tran, Weiwen Chen, Dunia Alarkawi, Dima A. Alajlouni, Fiona Blyth, Lyn March, Kristine Ensrud, Robert D. Blank, Jacqueline R. Center
SSRN Electronic Journal .2022;[Epub] CrossRef The effect of exercise intensity on bone in postmenopausal women (part 1): A systematic review
Melanie Kistler-Fischbacher, Benjamin K. Weeks, Belinda R. Beck
Bone.2021; 143: 115696. CrossRef Pharmacological Management of Postmenopausal Osteoporosis: a Level I Evidence Based - Expert Opinion
Filippo Migliorini, Giorgia Colarossi, Alice Baroncini, Jörg Eschweiler, Markus Tingart, Nicola Maffulli
Expert Review of Clinical Pharmacology.2021; 14(1): 105. CrossRef The impact of bisphosphonates on postoperative complication rates in osteoporotic patients undergoing posterior lumbar fusion
Sidney Roberts, Blake Formanek, Zorica Buser, Jeffrey C. Wang
European Spine Journal.2021; 30(5): 1329. CrossRef Efficacy of annual zoledronic acid in initial percutaneous kyphoplasty patients with osteoporotic vertebral compression fractures: a 3-year follow-up study
K. Lu, Y. Yin, C. Li, Y. Jin, H.-q. Shan
Osteoporosis International.2021; 32(7): 1429. CrossRef Risks, Benefits, and Treatment Modalities of Menopausal Hormone Therapy: Current Concepts
Jaya Mehta, Juliana M. Kling, JoAnn E. Manson
Frontiers in Endocrinology.2021;[Epub] CrossRef Optimal Dosing Regimen of Osteoporosis Drugs in Relation to Food Intake as the Key for the Enhancement of the Treatment Effectiveness—A Concise Literature Review
Agnieszka Wiesner, Mariusz Szuta, Agnieszka Galanty, Paweł Paśko
Foods.2021; 10(4): 720. CrossRef Cancer Treatment–Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy
Anna Diana, Francesca Carlino, Emilio Francesco Giunta, Elisena Franzese, Luigi Pio Guerrera, Vincenzo Di Lauro, Fortunato Ciardiello, Bruno Daniele, Michele Orditura
Current Treatment Options in Oncology.2021;[Epub] CrossRef The Impact of COVID-19 on the Optimal Management of Osteoporosis
Sung Hye Kong, Bo Kwon Hwang, Byung-Ho Yoon
Journal of Bone Metabolism.2021; 28(2): 115. CrossRef Zoledronic Acid in Osteoporotic Vertebral Compression Fractures Treated With Percutaneous Kyphoplasty: A Meta-Analysis
Peng Tian, Yue Liu, Zhi-jun Li, Gui-jun Xu, Xin-long Ma
Frontiers in Surgery.2021;[Epub] CrossRef Fragility Fractures: Risk Factors and Management in the Elderly
Filippo Migliorini, Riccardo Giorgino, Frank Hildebrand, Filippo Spiezia, Giuseppe Maria Peretti, Mario Alessandri-Bonetti, Jörg Eschweiler, Nicola Maffulli
Medicina.2021; 57(10): 1119. CrossRef Effect of different hydration doses on renal function in patients with primary osteoporosis treated with zoledronic acid
Xin Dai, Yongtao Deng, Yetao Luo, Jianghong Xie, Houxun Ma
Medicine.2020; 99(25): e20831. CrossRef The Belgian Bone Club 2020 guidelines for the management of osteoporosis in postmenopausal women
D. Sanchez-Rodriguez, P. Bergmann, J.J. Body, E. Cavalier, E. Gielen, S. Goemaere, B. Lapauw, MR Laurent, S. Rozenberg, G. Honvo, C. Beaudart, O. Bruyère
Maturitas.2020; 139: 69. CrossRef Effect of bisphosphonates or teriparatide on mechanical complications after posterior instrumented fusion for osteoporotic vertebral fracture: a multi-center retrospective study
Atsuyuki Kawabata, Toshitaka Yoshii, Takashi Hirai, Shuta Ushio, Takashi Kaito, Tomoya Yamashita, Hiroyasu Fujiwara, Yukitaka Nagamoto, Yuji Matsuoka, Hidekazu Suzuki, Hirosuke Nishimura, Hidetomi Terai, Koji Tamai, Atsushi Tagami, Syuta Yamada, Shinji Ad
BMC Musculoskeletal Disorders.2020;[Epub] CrossRef The effectiveness and cost-effectiveness of an integrated osteoporosis care programme for postmenopausal women in Flanders: study protocol of a quasi-experimental controlled design
Caroline Verdonck, Lieven Annemans, Stefan Goemaere, Bruno Lapauw, Geert Goderis, Elie Balligand, Marie-Paule Doom, Stany Perkisas, Liesbeth Borgermans
Archives of Osteoporosis.2020;[Epub] CrossRef Bisphosphonate therapy in CKD
Matthew J. Damasiewicz, Thomas L. Nickolas
Current Opinion in Nephrology and Hypertension.2020; 29(2): 221. CrossRef Duration of Bisphosphonate Drug Holidays and Associated Fracture Risk
Jeffrey R. Curtis, Kenneth G. Saag, Tarun Arora, Nicole C. Wright, Huifeng Yun, Shanette Daigle, Robert Matthews, Elizabeth Delzell
Medical Care.2020; 58(5): 419. CrossRef Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates
P.D. Miller, N. Pannacciulli, J. Malouf-Sierra, A. Singer, E. Czerwiński, H.G. Bone, C. Wang, S. Huang, A. Chines, W. Lems, J.P. Brown
Osteoporosis International.2020; 31(1): 181. CrossRef Differences in the microarchitectural features of the lateral collapsed lesion between osteonecrosis and subchondral insufficiency fracture of the femoral head
Koichiro Kawano, Goro Motomura, Satoshi Ikemura, Ryosuke Yamaguchi, Shoji Baba, Mingjian Xu, Yasuharu Nakashima
Bone.2020; 141: 115585. CrossRef Three-Component Reaction of Diamines with Triethyl Orthoformate and Diethyl Phosphite and Anti-Proliferative and Antiosteoporotic Activities of the Products
Patrycja Petruczynik, Paweł Kafarski, Mateusz Psurski, Joanna Wietrzyk, Zdzisław Kiełbowicz, Jan Kuryszko, Ewa Chmielewska
Molecules.2020; 25(6): 1424. CrossRef Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment
Ourania Nicolatou-Galitis, Morten Schiødt, Rui Amaral Mendes, Carla Ripamonti, Sally Hope, Lawrence Drudge-Coates, Daniela Niepel, Tim Van den Wyngaert
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.2019; 127(2): 117. CrossRef Bisphosphonate treatment changes regional distribution of trabecular microstructure in human lumbar vertebrae
Annika vom Scheidt, Haniyeh Hemmatian, Klaus Püschel, Matthias Krause, Michael Amling, Björn Busse
Bone.2019; 127: 482. CrossRef Bisphosphonates for Secondary Prevention of Osteoporotic Fractures: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
Lei Shi, Nan Min, Fei Wang, Qing-Yun Xue
BioMed Research International.2019; 2019: 1. CrossRef Bisphosphonates and cardiovascular risk in elderly patients with previous cardiovascular disease: a population-based nested case-control study in Italy
Ursula Kirchmayer, Chiara Sorge, Janet Sultana, Francesco Lapi, Graziano Onder, Nera Agabiti, Silvia Cascini, Giuseppe Roberto, Giovanni Corrao, Cristiana Vitale, Ersilia Lucenteforte, Alessandro Mugelli, Marina Davoli, C. Bartolini, R. Bernabei, A Bettio
Therapeutic Advances in Drug Safety.2019; 10: 204209861983813. CrossRef Microcirculatory consequences of limb ischemia/reperfusion in ovariectomized rats treated with zoledronic acid
Levente Pócs, Ágnes Janovszky, Imre Ocsovszki, József Kaszaki, József Piffkó, Andrea Szabó
Journal of Orthopaedic Surgery and Research.2019;[Epub] CrossRef Prolonged Effect of Zoledronic Acid on Bone Mineral Density and Turnover in HIV-Infected Adults on Tenofovir: A Randomized, Open-Label Study
Andrew Carr, Stephen J Kerr, Robyn Richardson, Peter Ebeling, Nicholas Pocock, Jhon Rojas, Esteban Martinez, Jennifer Hoy
Journal of Bone and Mineral Research.2019; 34(12): 2192. CrossRef Efficacy, cost, and aspects to take into account in the treatment of osteoporosis in the elderly
Pilar Sáez-López, Iñigo Etxebarria-Foronda, Maria Pilar Mesa Lampre, Noelia Alonso García, Natalia Sánchez Hernández
Revista Española de Geriatría y Gerontología.2019; 54(3): 156. CrossRef Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures
Serena Varesano, Maria Raffaella Zocchi, Alessandro Poggi
Frontiers in Immunology.2018;[Epub] CrossRef Screening for osteoporosis: A systematic assessment of the quality and content of clinical practice guidelines, using the AGREE II instrument and the IOM Standards for Trustworthy Guidelines
Lamia M. Hayawi, Ian D. Graham, Peter Tugwell, Said Yousef Abdelrazeq, Bart O. Williams
PLOS ONE.2018; 13(12): e0208251. CrossRef Sobrediagnóstico en la salud de la mujer: el caso de la osteoporosis
Elena Cardona Corrochano, Ana Pereira Iglesias, David Fraile Navarro, Alberto López García Franco
Atención Primaria.2018; 50: 30. CrossRef Hip fracture risk in patients with alcoholic cirrhosis: A population-based study using English and Danish data
Harmony Otete, Thomas Deleuran, Kate M. Fleming, Tim Card, Guru P. Aithal, Peter Jepsen, Joe West
Journal of Hepatology.2018; 69(3): 697. CrossRef The role of biphosphonates in the management of thalassemia-induced osteoporosis: a systematic review and meta-analysis
Athanasios N. Tsartsalis, George I. Lambrou, Dimitrios Tsartsalis, Christos Savvidis, Maria Karantza, Evangelos Terpos, Christina Kanaka-Gantenbein, George P. Chrousos, Antonis Kattamis
Hormones.2018; 17(2): 153. CrossRef The underlying pathophysiology and therapeutic approaches for osteoporosis
Harshika Awasthi, Dayanandan Mani, Divya Singh, Atul Gupta
Medicinal Research Reviews.2018; 38(6): 2024. CrossRef Targeting therapeutics to bone by conjugation with bisphosphonates
Robert N Young, Marc D Grynpas
Current Opinion in Pharmacology.2018; 40: 87. CrossRef The bone remodelling cycle
JS Kenkre, JHD Bassett
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine.2018; 55(3): 308. CrossRef Clinical Management of Osteoporotic Fractures
Adam Z. Khan, Richard D. Rames, Anna N. Miller
Current Osteoporosis Reports.2018; 16(3): 299. CrossRef Can Bisphosphonates Prevent Recurrent Fragility Fractures? A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Sang Yoon Lee, Se Hee Jung, Shi-Uk Lee, Yong-Chan Ha, Jae-Young Lim
Journal of the American Medical Directors Association.2018; 19(5): 384. CrossRef
|